Can inflammation related diseases increase risk of primary acquired nasolacrimal duct obstruction?
Primary Acquired Nasolacrimal Duct Obstruction (PANDO) has long been a concern for patients, impacting their ocular health. A recent retrospective case-control study conducted by Clalit Health Services in Israel delves into the intricate associations between PANDO and various inflammatory conditions. The findings shed light on the multifaceted nature of PANDO, revealing significant connections with ocular […]